Male Reproductive & Renal Disorders — NCLEX Nursing Lesson Anatomy & Physiology · RN Track · Medical-Surgical Body Systems · Reproductive / Renal System · Male Reproductive & Renal Disorders Condition Lesson · NCLEX-PN / NCLEX-RN

BPH, renal cell carcinoma, prostate cancer, and testicular cancer—why an enlarged prostate blocks urine, what "pink not red" means after a TURP, and the screening that catches these early.

In this lesson

Lesson Objectives
Why This Matters
Disease Overview
What They Look Like
Pathophysiology
Risk Factors
Signs & Symptoms
Nursing Assessment
Diagnostic Tests
Laboratory Tests
Medications
Nursing Interventions
Complications
Patient Education
Clinical Judgment
Clinical Connections
NCLEX High-Yield
Memory Aids
Case Study
Practice Questions
Key Takeaways
References

Lesson Objectives

Differentiate BPH, renal cell carcinoma, prostate cancer, and testicular cancer by cause, findings, and priority nursing care.
Explain how each disrupts normal urinary/reproductive function and why the classic symptoms occur.
Justify treatments—alpha-blockers, 5-alpha reductase inhibitors, TURP with continuous bladder irrigation, nephrectomy, orchiectomy, hormone therapy—and the reasoning behind each.
Recognize the emergencies (post-TURP hemorrhage, urinary retention, testicular torsion) and interpret key labs/markers (PSA, tumor markers).
Promote screening and self-exams, and use the NCSBN Clinical Judgment model.

Why This Matters

Prevalence: BPH is extremely common—most men develop it with age (very common after 50). Prostate cancer is one of the most common cancers in men; renal cell carcinoma is the most common kidney cancer (often linked to smoking); and testicular cancer is the most common solid cancer in young men (ages ~15–35) and is highly curable.

Patient safety: BPH can cause acute urinary retention (an emergency) and post-op TURP hemorrhage; the cancers can bleed, obstruct, and metastasize (prostate → bone; renal → lung/bone). Early recognition and screening change outcomes.

NCLEX importance: heavily tested on BPH urinary symptoms and medications, TURP care (continuous bladder irrigation, "pink not red" urine, hemorrhage), PSA and prostate cancer, the renal cell carcinoma triad, and testicular self-exam/cure. Builds on the A&P of the prostate, urethra, kidneys, and testes.

Why nurses encounter it constantly: nurses manage urinary retention and catheters, provide post-TURP and post-nephrectomy/orchiectomy care, teach medications and screening, and support cancer treatment—daily urology and med-surg nursing.

Connecting to prior lessons From A&P, recall that the prostate surrounds the urethra (so enlargement obstructs urine flow), the kidneys filter blood, and the testes make sperm/testosterone. From assessment, recall urinary symptoms, PSA/DRE, hematuria, flank pain, and testicular self-exam. These disorders are the prostate blocking flow or cancer arising in the kidney, prostate, or testis.

Disease Overview

Disorder	Core problem & meaning
Benign prostatic hyperplasia (BPH)	Non-cancerous enlargement of the prostate that compresses the urethra → obstructive urinary symptoms (weak stream, retention). Common with aging.
Renal cell carcinoma (RCC)	The most common kidney cancer; often silent until late. Classic (late) triad: hematuria, flank pain, and a palpable flank mass. Strongly linked to smoking.
Prostate cancer	Malignant tumor of the prostate—often slow-growing; detected via PSA/DRE. Tends to metastasize to bone (back pain).
Testicular cancer	Cancer of the testis, mostly in young men (15–35); presents as a painless testicular lump. Uses tumor markers and is highly curable.

Analogy — a hose clamp and three warning lights

The prostate wraps around the urethra like a ring around a garden hose. In BPH, that ring swells and squeezes the hose—so the "stream" gets weak, starts and stops, and urine can back up (retention). The cancers are different: think of them as warning lights in three organs—kidney (RCC → blood in urine, flank pain), prostate (cancer → detected by PSA, spreads to bone), and testis (a painless lump in a young man). BPH is a plumbing problem; the cancers are cell-growth problems—but all live in the male GU system.

What They Look Like

BPH compressing the urethra & the male GU cancers NORMAL Open urethra → normal stream BPH Enlarged → squeezes urethra (weak stream, retention) THE MALE GU CANCERS Renal cell (kidney) hematuria, flank pain, mass Prostate ↑PSA; spreads to bone Testicular painless lump (young men) After a TURP (BPH surgery): Continuous bladder irrigation keeps clots from forming — urine should be pink, not red

BPH is an obstruction (enlarged prostate squeezing the urethra). The three cancers are cell-growth problems in the kidney (RCC), prostate, and testis—each with its own hallmark. After a TURP, watch the irrigation: bright red or clots = hemorrhage.

Pathophysiology

Normal physiology: the prostate is small and surrounds the urethra without blocking it; urine flows freely from the bladder; the kidneys filter blood; the testes make sperm. ↓ What goes wrong: BPH = age/hormone-related prostate enlargement compresses the urethra. Cancers = abnormal cell growth in the kidney (RCC), prostate, or testis (risk from smoking, age, genetics, or—rarely—undescended testis). ↓ How symptoms appear: BPH → weak stream, hesitancy, frequency, nocturia, incomplete emptying, and retention (urethral obstruction). RCC → hematuria, flank pain, and a mass (late). Prostate cancer → often silent early; later obstructive symptoms and bone pain (metastasis). Testicular cancer → a painless firm lump. ↓ How it progresses: BPH → acute retention, UTIs, bladder/kidney damage. Cancers → local growth, bleeding, obstruction, and metastasis (prostate→bone; RCC→lung/bone). Screening, medications, and surgery interrupt these paths. NCLEX Clinical Pearl — BPH is obstruction; the cancers are growth BPH is benign—an enlarged prostate causing obstructive urinary symptoms (weak stream, retention). It does not become cancer, but a man can have both. Prostate cancer is often silent early (found on PSA/DRE) and spreads to bone. RCC's late triad is hematuria + flank pain + palpable mass. Testicular cancer = a painless lump in a young man (do TSE).

Risk Factors

Non-modifiable	Modifiable	Preventable / reducible
Older age (BPH, prostate/renal cancer) Family history/genetics (prostate/RCC) Black race (higher prostate-cancer risk/mortality) Undescended testis (testicular cancer); young age 15–35	Smoking (RCC—major), obesity, hypertension (RCC) Diet high in fat/red meat (prostate) Occupational chemical exposure (RCC)	Smoking cessation (RCC); manage weight/BP Healthy diet Screening (PSA/DRE) and testicular self-exam for early detection

High-risk populations: older men and those with a family history (BPH, prostate/renal cancer); Black men (higher prostate-cancer risk/mortality); smokers (RCC); and young men (15–35), especially with a history of undescended testis (testicular cancer). Smoking is the biggest modifiable risk for RCC.

Signs & Symptoms

Category	Findings & WHY they occur
BPH (obstructive/irritative)	Weak/interrupted stream, hesitancy, straining, incomplete emptying, dribbling, frequency, urgency, and nocturia—the enlarged prostate obstructs and irritates the bladder outlet.
Renal cell carcinoma	Often silent early; late classic triad: hematuria (blood in urine), flank pain, and a palpable flank mass; also weight loss and fatigue.
Prostate cancer	Often asymptomatic early (found on PSA/DRE); later obstructive urinary symptoms, hematuria, and bone pain (metastasis).
Testicular cancer	A painless, firm lump or swelling in the testis; a feeling of heaviness—an abnormal cell growth.
Emergency findings	Acute urinary retention (BPH—unable to void, distended painful bladder), post-TURP hemorrhage (bright red urine/clots, ↓BP), and testicular torsion (sudden severe scrotal pain)—act now.

Why acute urinary retention is an emergency In BPH, the prostate can completely block urine flow—the bladder fills, distends, and can't empty, causing severe pain and possible kidney damage (backup). The patient can't void despite urgency. This is acute urinary retention—an emergency needing immediate bladder decompression (catheterization) and provider notification.

Nursing Assessment

Subjective: urinary pattern (stream, hesitancy, frequency, nocturia, retention), hematuria, flank/back/bone pain, testicular lumps/heaviness, weight loss/fatigue, smoking, family history, and screening history.

Objective: bladder distention/retention (palpate/scan), urine (hematuria, output), vital signs, DRE findings (by provider), flank/testicular exam, and (post-op) irrigation drainage color. Correlate with PSA, creatinine, and tumor markers.

Priority / focused finding	Why it matters / action
Inability to void + distended bladder	Acute urinary retention—decompress (catheter), notify.
Bright red urine/clots post-TURP	Hemorrhage—increase/maintain irrigation, VS, notify.
Hematuria + flank pain + mass	RCC—report; further workup.
Painless testicular lump (young man)	Testicular cancer—report; TSE teaching.
New back/bone pain (prostate cancer)	Possible bone metastasis—assess and report.

Red flags — notify / act now Acute urinary retention (can't void, distended painful bladder), post-TURP hemorrhage (bright red urine/clots, hypotension/tachycardia), testicular torsion (sudden severe scrotal pain), and signs of obstruction/AKI (rising creatinine, anuria). Act immediately.

Diagnostic Tests

Test	Purpose / why ordered	Findings, prep & nursing considerations
Digital rectal exam (DRE)	Assess prostate size/consistency (BPH vs. cancer)	BPH = smooth/rubbery/enlarged; cancer = hard/nodular. Explain and provide privacy.
PSA (blood)	Screen/monitor prostate cancer (and BPH)	Elevated with cancer, BPH, or prostatitis; draw before DRE (manipulation can raise it); trend over time. Finasteride lowers PSA.
Bladder scan / post-void residual	Assess retention/emptying (BPH)	High residual = incomplete emptying/retention. Noninvasive.
Urinalysis / cytology	Detect hematuria/infection/cancer cells	Hematuria → workup (RCC, bladder cancer).
Imaging (CT/ultrasound/MRI)	Evaluate kidney mass (RCC), staging, testicular mass	Ultrasound for testicular masses; CT for RCC/staging. Contrast precautions.
Biopsy (prostate/kidney)	Confirm cancer diagnosis/grade (Gleason for prostate)	Post-biopsy: monitor for bleeding/infection. Testicular masses are usually removed (orchiectomy)—biopsy is generally avoided to prevent spread.

Patient teaching — PSA & screening Explain that PSA is a screening/monitoring tool (elevated by cancer, BPH, prostatitis, or recent manipulation), that it's drawn before the DRE, and that finasteride lowers PSA (so results are interpreted accordingly). Reinforce testicular self-exam for young men and shared decision-making about prostate screening.

Laboratory Tests

Lab	Normal range	Significance & trend
PSA (prostate-specific antigen)	<4 ng/mL (age-related)	Elevated in prostate cancer, BPH, or prostatitis; a rising trend is concerning. Used to monitor cancer treatment/recurrence. Finasteride roughly halves PSA.
Creatinine / BUN	Cr 0.6–1.2 mg/dL	Rise with obstruction (BPH backup) or kidney impairment (RCC/post-nephrectomy)—monitor renal function.
Hemoglobin & hematocrit	Hgb ~13–17 g/dL	Low with hematuria/bleeding (post-TURP, RCC); RCC can also cause polycythemia (high) via EPO.
Testicular tumor markers — AFP, β-hCG, LDH	Low/negative	Elevated in testicular cancer—used to diagnose, stage, and monitor treatment response/recurrence.
Urinalysis / cytology	No blood/cancer cells	Hematuria or malignant cells → cancer workup.

NCLEX pearl — know PSA and the testicular markers PSA screens/monitors prostate cancer (elevated also by BPH/prostatitis/manipulation; lowered by finasteride). AFP, β-hCG, and LDH are testicular cancer tumor markers used to diagnose and track treatment. Watch creatinine (obstruction/kidney) and H&H (bleeding).

Medications

BPH medications

Class / drug	Mechanism, use & key nursing/NCLEX points
Alpha-1 blockers — tamsulosin, doxazosin, terazosin ("-osin")	Relax smooth muscle in the prostate/bladder neck → improve urine flow quickly. Cause orthostatic hypotension/dizziness—take at bedtime, rise slowly, fall precautions; watch "floppy iris" (tell the eye surgeon before cataract surgery). Don't relieve the enlargement itself.
5-alpha reductase inhibitors — finasteride, dutasteride	Shrink the prostate over months by blocking DHT. Takes 3–6 months; lowers PSA (~50%); teratogen—pregnant women should not handle crushed/broken tablets (fetal harm); may reduce libido.
PDE-5 inhibitors — tadalafil (select cases)	Can relieve BPH/ED symptoms. Avoid with nitrates (severe hypotension).

Cancer therapy

Therapy	Why given & nursing
Hormone (androgen deprivation) therapy — leuproTide, goserelin; anti-androgens	Lower testosterone (which fuels prostate cancer). Side effects: hot flashes, ↓libido/ED, bone loss (osteoporosis), and metabolic changes—monitor and support.
Chemotherapy (testicular—highly curable; advanced prostate/RCC)	Kills cancer cells. Myelosuppression/infection/bleeding risk; monitor counts; handle as hazardous drugs; testicular cancer chemo (e.g., cisplatin-based) is very effective.
Targeted/immunotherapy (RCC)	Tyrosine kinase inhibitors/immunotherapy for advanced RCC (RCC resists standard chemo). Monitor for specific toxicities.
Analgesics (bone pain—prostate)	Manage metastatic bone pain; support quality of life.

Safety — alpha-blocker dizziness & finasteride handling Alpha-blockers cause orthostatic hypotension—teach to rise slowly, take the first dose at bedtime, and use fall precautions. Finasteride is a teratogen—pregnant women must not handle broken/crushed tablets, and it lowers PSA (interpret screening accordingly). For hormone therapy, monitor for bone loss and metabolic effects. NCLEX testing points BPH → alpha-blockers ("-osin," fast relief, orthostatic hypotension) and 5-ARIs (finasteride, shrink over months, lower PSA, teratogen). Prostate cancer → hormone (androgen deprivation) therapy. Testicular cancer → orchiectomy + chemo (curable), tumor markers. RCC → nephrectomy + targeted/immunotherapy; smoking cessation.

Nursing Interventions

Priority	Intervention & WHY
Circulation (post-TURP hemorrhage)	Maintain continuous bladder irrigation (CBI), keep urine pink (not red/clotted), monitor VS and H&H, and increase the irrigation rate if bleeding/clots appear; notify for bright red bleeding—prevent clot obstruction and hemorrhage.
Relieve/prevent retention (BPH)	Assess bladder distention, catheterize for acute retention, monitor output, and give alpha-blockers—restore urine flow and protect the kidneys.
Catheter/irrigation care	Keep the catheter patent (traction/taping per order after TURP), monitor I&O (subtract irrigant), and prevent infection—maintain drainage and comfort.
Safety (meds)	Fall precautions with alpha-blockers (orthostatic hypotension); teach finasteride handling (teratogen); monitor for bleeding/infection on chemo.
Comfort	Manage bladder spasms (antispasmodics), incisional/bone pain, and provide emotional support (sexual function, cancer diagnosis).
Patient education	Medications, self-exam/screening, catheter/wound care, fluid intake, and warning signs—self-management and early detection.
Interdisciplinary	Urology, oncology, radiation, pharmacy, and support/psychosocial services (fertility, sexuality, cancer support).

Why "pink not red" and CBI matter after a TURP A TURP removes prostate tissue through the urethra, leaving a raw, vascular surface that bleeds. Continuous bladder irrigation constantly flushes the bladder so blood doesn't clot and block the catheter. The nurse titrates the irrigation to keep urine light pink—bright red or clots mean bleeding (speed up irrigation, notify), while clear/very pale means you can slow it. Watch for clot obstruction (bladder spasms, decreased output, distention).

Potential Complications

Complication	Early signs	Nursing response
Post-TURP hemorrhage	Bright red urine/clots, ↓BP, ↑HR, ↓H&H, bladder distention	Emergency: increase CBI, VS, notify provider, monitor for shock; manual irrigation for clots per order.
Acute urinary retention (BPH)	Unable to void, distended painful bladder	Emergency decompression: catheterize, notify provider, monitor output/renal function.
Clot obstruction / bladder spasms (post-TURP)	Decreased output, bladder distention, painful spasms	Check/irrigate catheter for patency, give antispasmodics, maintain CBI.
Metastasis (prostate→bone, RCC→lung/bone)	Bone pain, fractures, weight loss	Symptom/pain management, oncology care, support.
Infection / UTI	Fever, dysuria, cloudy urine	Cultures, antibiotics, catheter care.
Erectile dysfunction / infertility (treatment)	Reported after surgery/hormone therapy	Teaching, counseling, fertility referral (sperm banking before treatment).

Patient Education

Disease process: explain whether the issue is a benign enlarged prostate obstructing urine (BPH) or a cancer of the kidney, prostate, or testis, and how treatment works. BPH: take alpha-blockers as prescribed (rise slowly—dizziness), understand finasteride takes months and that pregnant women shouldn't handle the tablets; avoid bladder irritants (caffeine, alcohol) and drugs that worsen retention (some antihistamines/decongestants); don't over- or under-drink. After TURP: expect pink-tinged urine and some clots initially, drink plenty of fluids, avoid straining/heavy lifting/constipation (can cause bleeding), and report bright red bleeding or inability to void. Screening/self-exam: perform monthly testicular self-exam (young men—report painless lumps) and discuss prostate screening (PSA/DRE) and smoking cessation (RCC). Cancer/sexuality/fertility: discuss possible ED/infertility and sperm banking before treatment; provide support. Follow-up: keep PSA/tumor-marker and imaging appointments. Warning signs / when to seek emergency care: inability to urinate, heavy bright red bleeding, severe scrotal pain, fever, or severe flank/bone pain—seek care.

Clinical Judgment (NCSBN Model)

Recognize cues: a client is 6 hours post-TURP with continuous bladder irrigation. The nurse notes the drainage has turned bright red with clots, output is decreasing, the client reports bladder fullness/spasms, and vitals show HR 110, BP 98/58.
Analyze cues: bright red drainage + clots + decreasing output + distention + tachycardia/falling BP = post-TURP hemorrhage with possible clot obstruction—the raw prostatic bed is bleeding and clots may be blocking flow.
Prioritize hypotheses: hemorrhage/clot obstruction is the priority—maintain drainage and control bleeding to prevent shock and bladder distention.
Generate solutions: increase the CBI rate, assess/irrigate the catheter for clots per order (manual irrigation if obstructed), monitor VS and H&H, ensure catheter traction/patency, notify the provider, and prepare for possible transfusion/return to OR.
Take action: speed up irrigation, clear clots, monitor closely, and notify—stop the bleeding and keep urine flowing.
Evaluate outcomes: is the urine returning to pink, output improving, and are VS stabilizing? Then teach post-op precautions (fluids, no straining) and warning signs.

Clinical Connections — commonly confused

	BPH	Prostate Cancer	Renal Cell Carcinoma	Testicular Cancer
Cause/nature	Benign enlargement	Malignant (prostate)	Malignant (kidney)	Malignant (testis)
Key sign	Obstructive urinary symptoms	Often silent; ↑PSA; bone pain (mets)	Hematuria + flank pain + mass (late)	Painless testicular lump (young men)
Diagnostics	DRE, PSA, bladder scan	PSA/DRE, biopsy (Gleason)	CT/ultrasound, urinalysis	Ultrasound, tumor markers (AFP/hCG/LDH)
Treatment	Alpha-blockers, 5-ARIs, TURP	Surgery, radiation, hormone therapy	Nephrectomy, targeted/immunotherapy	Orchiectomy + chemo (curable)
Priority nursing	Relieve retention, post-TURP CBI	Screening, hormone-therapy support	Post-nephrectomy, smoking cessation	TSE teaching, fertility/support

Key confusion: BPH is benign obstruction—it doesn't become cancer (though both can coexist). PSA rises in BPH, prostatitis, and cancer (and after manipulation), so it's interpreted in context. Testicular cancer is a painless lump (vs. torsion, which is severe pain).

NCLEX High-Yield Review

What the NCLEX Wants You to Know

Post-TURP: keep urine PINK not red; bright red/clots = hemorrhage → speed up CBI
BPH = obstructive urinary symptoms; watch for acute retention
Alpha-blockers ("-osin") = orthostatic hypotension; finasteride = teratogen, lowers PSA
RCC triad = hematuria + flank pain + mass; smoking is key risk
Testicular cancer = painless lump in young men; do TSE; highly curable

Frequently tested findings: BPH urinary symptoms/retention, post-TURP bleeding, hematuria (RCC), ↑PSA, painless testicular lump. Common distractors: slowing CBI when urine is bright red, letting a pregnant woman handle finasteride, assuming BPH becomes cancer, and delaying care for retention. Priority interventions: post-TURP hemorrhage → increase CBI/notify; acute retention → catheterize; safety with alpha-blockers. Expected vs unexpected: pink-tinged urine and small clots early after TURP are expected; bright red bleeding, inability to void, or severe scrotal pain are emergencies. Patient teaching: med timing/handling, TSE and screening, post-TURP fluids/no straining, smoking cessation. Safety: fall precautions (alpha-blockers), finasteride handling, catheter/CBI care, chemo precautions. Delegation: RN assesses, interprets labs, manages CBI/hemorrhage; UAP can take vitals, measure I&O, assist with hygiene, and report urine color—not assess or medicate. Frequently tested meds: tamsulosin/doxazosin, finasteride, leuprolide, chemotherapy. Critical labs: PSA, creatinine, H&H, testicular tumor markers. Most common mistakes: mismanaging CBI, missing retention, and mishandling finasteride.

Memory Aids

Post-TURP "Pink is good, Red is bad": keep the irrigation output light pink; bright red/clots → speed up CBI and notify.
Alpha-blockers "-osin" → "Orthostatic": rise slowly, fall precautions; also "floppy iris" before cataract surgery.
Finasteride "Fetal risk + Falls PSA": teratogen (no handling by pregnant women); lowers PSA; takes months.
RCC triad "Blood, Back, Bulge": hematuria, flank (back) pain, palpable mass — plus smoking.
Testicular cancer "Young, Lump, No pain": 15–35, painless lump → do TSE; highly curable (markers AFP/hCG/LDH).
BPH symptoms "weak, wait, wake": weak stream, hesitancy (wait), nocturia (wake).

Case Study — from admission to discharge

Admission. Mr. Bianchi, 71, with BPH, is admitted with acute urinary retention (unable to void, distended painful bladder). He is catheterized with relief, then undergoes a TURP. Post-op, he has a 3-way catheter with continuous bladder irrigation. A few hours later the nurse notes the drainage becoming darker red with small clots, and he reports bladder spasms.

Step 1–2: Recognize & analyze cues

Cues: BPH → acute retention (obstruction) → TURP. Post-op reddening drainage + clots + bladder spasms = expected some bleeding, but watch for hemorrhage/clot obstruction (the prostatic bed bleeds).

Step 3–4: Prioritize & plan

Priority: maintain catheter patency and control bleeding. Plan: increase the CBI rate to keep urine pink, assess/irrigate for clots per order, give antispasmodics, monitor VS/H&H and I&O (subtract irrigant), maintain catheter traction, and notify the provider for bright red bleeding.

Step 5: Take action

The nurse speeds up the irrigation, checks the catheter for clots, gives an antispasmodic, monitors output/VS, and keeps the catheter secured. Urine lightens back to pink and spasms ease.

Step 6: Evaluate & discharge

Bleeding resolves, urine is pink, and he voids after catheter removal. Discharge teaching: drink plenty of fluids, avoid straining/heavy lifting/constipation (bleeding risk), expect some pink urine for a while, avoid bladder irritants, take medications as prescribed, and seek care for bright red bleeding or inability to void.

NCLEX Practice Questions

Answer choices are numbered; the correct answer is given as a number.

1. A client is 4 hours post-TURP with continuous bladder irrigation. The nurse notes bright red urine with clots and a decreasing output. What is the nurse's priority action?

Stop the bladder irrigation
Clamp the catheter and notify no one
Encourage the client to ambulate
Increase the irrigation rate and assess the catheter for clots, then notify the provider

Rationale

Answer: 4. Bright red urine with clots and decreasing output suggest hemorrhage/clot obstruction—increase the CBI to flush clots, assess catheter patency, and notify the provider. Stopping irrigation (1) or clamping (2) allows clots to form/obstruct, and ambulation (3) doesn't address the bleeding.

2. A client with BPH is prescribed tamsulosin. Which teaching is most important?

Change positions slowly because the drug can cause dizziness and low blood pressure
Expect the medication to shrink the prostate within 24 hours
Take the medication only when symptoms are severe
Stop the drug if urine becomes lighter in color

Rationale

Answer: 1. Alpha-blockers like tamsulosin cause orthostatic hypotension/dizziness—teach to rise slowly and use fall precautions (take the first dose at bedtime). They relax muscle for fast relief but don't shrink the prostate (2), are taken regularly not PRN (3), and urine color (4) is irrelevant here.

3. A nurse reviews teaching about finasteride with a client and his family. Which statement requires follow-up?

"This medicine can take several months to work."
"It may lower my PSA level."
"My pregnant wife can safely handle my crushed tablets."
"It works by shrinking the prostate over time."

Rationale

Answer: 3. Finasteride is a teratogen—pregnant women should not handle crushed or broken tablets (fetal harm), so this statement needs correction. It does take months (1), lowers PSA (2), and shrinks the prostate (4)—all correct.

4. Which set of findings is the classic (late) presentation of renal cell carcinoma?

Painless testicular lump and heaviness
Hematuria, flank pain, and a palpable flank mass
Weak urinary stream and nocturia
Bone pain with an elevated PSA

Rationale

Answer: 2. The classic late triad of renal cell carcinoma is hematuria, flank pain, and a palpable flank mass. A painless testicular lump (1) is testicular cancer, weak stream/nocturia (3) is BPH, and bone pain with ↑PSA (4) suggests metastatic prostate cancer.

5. A 25-year-old man reports finding a firm, painless lump on his testicle. What is the nurse's best response?

This finding should be evaluated promptly, as it may indicate testicular cancer
This is a normal finding in young men and needs no follow-up
This is almost certainly a harmless muscle knot
He should wait several months to see if it goes away

Rationale

Answer: 1. A firm, painless testicular lump in a young man may be testicular cancer and needs prompt evaluation (it is highly curable when caught early). It is not normal (2, 3) and should not be delayed (4).

6. SATA. Which findings after a TURP should the nurse report immediately? Select all that apply.

Bright red urine with numerous clots
A sudden drop in blood pressure with tachycardia
Light pink urine that is clearing
Absent urine output with bladder distention
A decreasing hemoglobin and hematocrit

Rationale

Answers: 1, 2, 4, 5. Bright red urine/clots, hypotension/tachycardia, absent output with distention (clot obstruction), and a falling H&H indicate hemorrhage/obstruction. Light pink, clearing urine (3) is an expected, reassuring finding.

7. SATA. Which teaching points are appropriate for a client recovering at home after a TURP? Select all that apply.

Drink plenty of fluids
Avoid straining, heavy lifting, and constipation
Expect some pink-tinged urine initially
Resume vigorous exercise and heavy lifting immediately
Report bright red bleeding or inability to urinate

Rationale

Answers: 1, 2, 3, 5. Fluids, avoiding straining/lifting/constipation, expecting some pink urine, and reporting red bleeding or retention are correct. Resuming heavy lifting immediately (4) can cause bleeding and is contraindicated.

8. Priority. A nurse is caring for four clients. Which client should the nurse assess first?

A client with BPH requesting information about tamsulosin
A client with a painless testicular lump scheduled for an ultrasound
A post-TURP client with bright red urine, clots, and a falling blood pressure
A client with prostate cancer asking about hormone therapy

Rationale

Answer: 3. Bright red urine with clots and a falling BP indicate post-TURP hemorrhage—a life-threatening emergency and the priority. The others are stable or routine.

9. Delegation. Which task can the RN appropriately delegate to unlicensed assistive personnel (UAP) for a post-TURP client?

Adjusting the continuous bladder irrigation rate
Measuring and recording vital signs and urine output, then reporting them
Assessing the urine color and interpreting bleeding
Teaching about post-operative activity restrictions

Rationale

Answer: 2. Measuring/recording vital signs and output and reporting them are within UAP scope. Adjusting CBI (1), assessing/interpreting bleeding (3), and teaching (4) require the licensed nurse.

10. NGN Case Study. A 68-year-old reports months of a weak urinary stream, hesitancy, frequent nighttime urination, and a feeling of incomplete emptying. Today he is unable to void and has a distended, painful lower abdomen. DRE reveals a smooth, enlarged prostate; PSA is mildly elevated; a bladder scan shows 700 mL of retained urine.

a) What is happening and which cues support it?
b) What are the priority nursing actions and key teaching?

Model answer

a) What's happening: BPH with acute urinary retention. Supporting cues: chronic obstructive symptoms (weak stream, hesitancy, nocturia, incomplete emptying), a smooth enlarged prostate (benign), mildly elevated PSA (BPH can raise it), and now inability to void with 700 mL retained and a distended painful bladder.

b) Priority actions/teaching: 1) relieve the retention—catheterize to decompress the bladder (monitor output), notify the provider, and protect renal function. 2) Anticipate alpha-blockers (teach orthostatic-hypotension precautions) ± 5-ARI/finasteride (months to work, lowers PSA, teratogen handling) and possibly TURP (then CBI—keep urine pink). 3) Teach to avoid bladder irritants and retention-worsening drugs (some antihistamines/decongestants). Evaluate: bladder decompressed, output restored, comfort improved, and understanding of medications and warning signs (inability to void, bleeding).

Key Takeaways

BPH = benign prostate enlargement compressing the urethra → obstructive urinary symptoms and acute retention; it does not become cancer.
Post-TURP: maintain continuous bladder irrigation, keep urine PINK not red; bright red/clots = hemorrhage → increase CBI, notify; teach no straining/lifting and lots of fluids.
BPH meds: alpha-blockers ("-osin") give fast relief but cause orthostatic hypotension; finasteride shrinks the prostate over months, lowers PSA, and is a teratogen (no handling by pregnant women).
Renal cell carcinoma: late triad hematuria + flank pain + mass; smoking is a major risk; treat with nephrectomy and targeted/immunotherapy.
Prostate cancer: often silent early, found on PSA/DRE; spreads to bone; treated with surgery/radiation/hormone (androgen deprivation) therapy.
Testicular cancer: a painless lump in a young man (15–35); teach TSE; uses tumor markers (AFP/hCG/LDH); highly curable (orchiectomy + chemo).
Emergencies: post-TURP hemorrhage, acute urinary retention, and testicular torsion—act immediately.

References

Hinkle, J. L., Cheever, K. H., & Overbaugh, K. J. (2022). Brunner & Suddarth's textbook of medical-surgical nursing (15th ed.). Wolters Kluwer/Lippincott.
Ignatavicius, D. D., Workman, M. L., Rebar, C. R., & Heimgartner, N. M. (2021). Medical-surgical nursing: Concepts for interprofessional collaborative care (10th ed.). Elsevier.
Silvestri, L. A., & Silvestri, A. E. (2023). Saunders comprehensive review for the NCLEX-RN examination (9th ed.). Elsevier.
Assessment Technologies Institute. (2023). ATI RN adult medical-surgical nursing review module (12th ed.). ATI Nursing Education.
Sandhu, J. S., Bixler, B. R., Dahm, P., Goueli, R., Kirkby, E., Stoffel, J. T., & Wilt, T. J. (2024). Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. Journal of Urology, 211(1), 11–19. https://doi.org/10.1097/JU.0000000000003698
American Cancer Society. (2024). Prostate, kidney, and testicular cancer: Detection, diagnosis, and treatment. https://www.cancer.org
National Institute of Diabetes and Digestive and Kidney Diseases. (2024). Prostate enlargement (benign prostatic hyperplasia). U.S. National Institutes of Health. https://www.niddk.nih.gov

Male Reproductive Disorders

You must be logged in to access this course

Welcome & Getting Started

Launch RN Simulator

Wellness Center

Nursing Foundations

Fundamentals & Safety

Pharmacology

Dosage Calculations

Leadership, Management & Delegation

Medical-Surgical Body Systems

Neurological System

Sensory System

Endocrine System

Respiratory System

Cardiovascular System

Hematologic/Immune/Lymphatic System

Gastrointestinal (GI) System

Renal & Genitourinary

Reproductive System

Musculoskeletal System

Integumentary System

Specialty Areas

Maternity

Infectious Diseases

Pediatrics

Mental Health

NCLEX Success Center

Clinical Judgment Practice

Prioritization Practice

Delegation Practice

Lab Values

Final Review